In the dynamic landscape of healthcare, access to specialized medications can be a game-changer for patients facing specific health challenges. Hayat Alhikmah, a prominent pharmaceutical entity, has emerged as a key player in distributing hope across the Middle East and…
In the ever-evolving world of medicine, breakthroughs in pharmaceuticals continue to provide hope and relief to patients facing challenging health conditions. One such innovation is the Kineret Injection, also known as anakinra injection. This remarkable medication, powered by the active…
A 42% of patients with heart failure have depression symptoms, a common co-morbidity linked to poor quality of life and a bad prognosis. In addition to having an adverse effect on everyday social and domestic activities, 1-3 depressive symptoms significantly…
Cystic fibrosis has inflammation as one of its primary pathological drivers. Current treatments are poor at controlling and halting the progression of inflammatory events, frequently made worse by concurrent infection. Using anakinra, a non-glycosylated recombinant version of IL-1Ra, offers a…
The pathophysiology of cardiovascular disease and protein-energy wasting, which are significant risk factors for morbidity and mortality in individuals with end-stage kidney disease, are linked to inflammation. Anti-cytokine therapy has been proposed to reduce inflammation and improve outcomes. Anakinra’s effectiveness,…
Subscribe to our
Newsletter
***We Promise, no spam!
We are pharmaceutical wholesaler based in Dubai with a sister company based in India. We bridge the geographical gaps for our customers by providing easy access of Generic drugs, Reference listed drug and Name patient Import service, along with temperature controlled product.
Quick Contacts
- Warehouse No. 4 Street No. 27, Al Qusais Industrial Area 1, Dubai, United Arab Emirates.
- +971 54 2188305
- +971 04 269 4022
- [email protected]
© 2023 Hayatalhikmah | All Rights Reserved.